ORFADIN
Identification of Orfadin
| No description |
Google image searchProduct monograph
Active ingredient
nitisinone, 5 MG
DIN: 02459701
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Prescription
Company: SWEDISH ORPHAN BIOVITRUM AB (PUBL)
Date: 17-FEB-2017
ATC:
- A16 — OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, ATC/DDD, )
- A16A — OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, ATC/DDD)
- A16AX — Various alimentary tract and metabolism products (ATC, ATC/DDD)
- A16AX04 — NITISINONE (ATC/DDD)
Reference brand drug: Orfadin
